IP Verse

Boehringer Ingelheim Animal Health Usa competitive analysis

Latest publications and patents of Boehringer Ingelheim Animal Health Usa New

Explore the latest publications and patents granted to Boehringer Ingelheim Animal Health Usa, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Boehringer Ingelheim Animal Health Usa

EP3554536
Oct 26, 2022Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising ThemGranted And Under Opposition
EP3035958
Oct 26, 2022Porcine Circovirus Type 2 (Pcv2) Subunit VaccineGranted And Under Opposition
EP2785374
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses ThereofPatent Maintained As Amended
EP2998315
Nov 3, 2021Newcastle Disease Virus Vectored Avian VaccinesPatent Maintained As Amended
EP3061454
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses ThereofRevoked
EP2275132
Mar 3, 2021Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemGranted And Under Opposition
EP3127551
Jul 29, 2020Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsGranted And Under Opposition
EP3320919
May 27, 2020Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsGranted And Under Opposition
EP2460820
Jun 19, 2019Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsRevoked
EP2481420
Feb 20, 2019Single Dose Anti-Pcv2 Pig VaccineGranted And Under Opposition

Latest oppositions filed by Boehringer Ingelheim Animal Health Usa

Explore patent oppositions filed by Boehringer Ingelheim Animal Health Usa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP1957110
Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products ThereofBAYERJun 22, 2021
EP2819699
Controlled Release Compositions And Their Methods Of UseBAYERFeb 19, 2020
EP2842569
One Dose Vaccination With Mycoplasma HyopneumoniaeZOETIS PJan 3, 2020
EP3041939
Recombinant Marek'S Disease Viruses And Uses ThereofCEVA SANT ANIMALEDec 24, 2019
EP2598151
Compositions For Treating Heartworm InfestationCEVA SANT ANIMALESep 25, 2019
EP2803265
Spot-On Pesticide CompositionSERGEANTS PET CARE PRODUCTSJul 22, 2019
EP2768964
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Newcastle Disease Virus AntigensINTERVETJul 9, 2019
EP2833910
Pcv/Mycoplasma Hyopneumoniae Combination VaccineZOETISApr 4, 2019
EP2833909
Pcv/Mycoplasma Hyopneumoniae/Prrs Combination VaccineZOETISFeb 7, 2019
EP3185899
Improved Hvt-Vectored Nd-Ibd VaccineINTERVETJul 16, 2018

Latest patents of Boehringer Ingelheim Animal Health Usa opposed by its competitors

Explore Boehringer Ingelheim Animal Health Usa's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3035958
Oct 26, 2022Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine2
EP3554536
Oct 26, 2022Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising Them1
EP2785374
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof1
EP2998315
Nov 3, 2021Newcastle Disease Virus Vectored Avian Vaccines1
EP3061454
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof2
EP2275132
Mar 3, 2021Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them3
EP3127551
Jul 29, 2020Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs3
EP3320919
May 27, 2020Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions2
EP2460820
Jun 19, 2019Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions3
EP2481420
Feb 20, 2019Single Dose Anti-Pcv2 Pig Vaccine2

Latest PTAB cases involving Boehringer Ingelheim Animal Health Usa

Discover the latest PTAB cases involving Boehringer Ingelheim Animal Health Usa, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 6, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim Animal Health Usa

PGR2022-00021Dec 22, 2021BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInstitution Denied
PGR2020-00076Jul 22, 2020BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Animal Health Usa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BOEHRINGER INGELHEIM ANIMAL HEALTH USA16302 - Balanced
CEVA SANTE ANIMALE213 - - Highly Aggressive
INTERVET113441Balanced
LABORATORIOS HIPRA7 - - - Highly Aggressive